why choose us

First received: April 12, 2023

Clinical Trial: Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis Optica

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Neuromyelitis Optica

Study Type: INTERVENTIONAL


Official Title: A Study on the Safety and Efficacy of Chimeric Antigen Receptor T Cells in the Treatment of Recurrent/Refractory Neuromyelitis Optica

Brief Summary: This is a single-arm, open-label, single-center, phase I study.The primary objective is to evaluate the safety of CD19 CAR-T therapy for patients with relapsed or refractory Neuromyelitis Optica, and to evaluate the pharmacokinetics of CD19 CAR-T in patients.

Read more